# A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60

> **NCT06970756** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Pneumococcal Diseases

## Interventions

- **BIOLOGICAL:** 26-valent Pneumococcal Conjugate Vaccine
- **BIOLOGICAL:** 13-valent Pneumococcal Conjugate Vaccine

## Key facts

- **NCT ID:** NCT06970756
- **Lead sponsor:** Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-27
- **Primary completion:** 2025-11-27
- **Final completion:** 2026-07-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06970756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06970756, "A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06970756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*